{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:54:38Z","timestamp":1787500478834,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ajog.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:34:12Z","timestamp":1528716852000},"page":"488.e1-488.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Randomized controlled trial of belladonna and opiate suppository during intravesical onabotulinum toxin A\u00a0injection"],"prefix":"10.1016","volume":"219","author":[{"given":"Edgar L.","family":"LeClaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Wykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa L.","family":"Winterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Bimali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajog.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.ajog.2018.06.004_bib3","first-page":"217","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ajog.2018.06.004_bib4","first-page":"1572","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment","volume":"193","author":"Gormley","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ajog.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ajog.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","article-title":"A\u00a0prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity","volume":"96","author":"Rajkumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.ajog.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.2015.974543","article-title":"Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions","volume":"15","author":"Chung","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ajog.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bju.13025","article-title":"Patient experience and satisfaction with onabotulinumtoxin A for refractory overactive bladder","volume":"116","author":"Malde","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.ajog.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ajog.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/nau.22750","article-title":"Alkalinized lidocaine versus lidocaine gel as local anesthesia prior to intra-vesical botulinum toxin (BoNTA) injections: a prospective, single center, randomized, double-blind, parallel group trial of efficacy and morbidity","volume":"35","author":"Nambiar","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajog.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-198207040-00002","article-title":"Rectal drug administration: clinical pharmacokinetic considerations","volume":"7","author":"de Boer","year":"1982","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ajog.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2648.2003.02972.x","article-title":"Postoperative pain assessment tools in day surgery: literature review","volume":"46","author":"Coll","year":"2004","journal-title":"J\u00a0Adv Nurs"},{"key":"10.1016\/j.ajog.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"491.e1","DOI":"10.1016\/j.ajog.2016.12.032","article-title":"Randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery","volume":"216","author":"Butler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.06.004_bib15","first-page":"6799","article-title":"Prophylactic belladonna suppositories on anesthetic recovery after robotic assisted laparoscopic prostatectomy","volume":"20","author":"Scavonetto","year":"2013","journal-title":"Can J Urol"},{"key":"10.1016\/j.ajog.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/nau.22642","article-title":"Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome","volume":"34","author":"Osborn","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ajog.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.ajog.2018.06.004_bib18","first-page":"2416","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J\u00a0Urol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:20:25Z","timestamp":1757589625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818304915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0002937818304915"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.06.004","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial of belladonna and opiate suppository during intravesical onabotulinum toxin A\u00a0injection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}